AIMC Topic: Remission Induction

Clear Filters Showing 31 to 40 of 41 articles

Artificial intelligence-enabled histology exhibits comparable accuracy to pathologists in assessing histological remission in ulcerative colitis: a systematic review, meta-analysis, and meta-regression.

Journal of Crohn's & colitis Jan 11, 2025
BACKGROUND AND AIMS: Achieving histological remission is a desirable emerging treatment target in ulcerative colitis (UC), yet its assessment is challenging due to high inter- and intraobserver variability, reliance on experts, and lack of standardiz...
Humans Artificial Intelligence Colitis, Ulcerative Pathologists Remission Induction
View on PubMed DOI

Prediction of Early Symptom Remission in Two Independent Samples of First-Episode Psychosis Patients Using Machine Learning.

Schizophrenia bulletin Jan 21, 2022
BACKGROUND: Validated clinical prediction models of short-term remission in psychosis are lacking. Our aim was to develop a clinical prediction model aimed at predicting 4-6-week remission following a first episode of psychosis.
Adolescent Cohort Studies Support Vector Machine Models, Statistical Remission Induction Female Young Adult Adult Male Schizophrenia Psychotic Disorders Outcome Assessment, Health Care Remission, Spontaneous Humans Prognosis
View on PubMed DOI

[A Case of Descending Colon and Rectal Cancer with Acute Myeloid Leukemia Performed Robot‒Assisted Hartmann's Procedure].

Gan to kagaku ryoho. Cancer & chemotherapy Apr 1, 2021
The case is a 68‒year‒old male, who had been diagnosed with acute myeloid leukemia(AML)prior to rectal cancer surgery, was referred to our hospital for treatment in July 2019. We planned to treat the AML first, and then the colorectal cancer. After c...
Male Antineoplastic Combined Chemotherapy Protocols Robotics Remission Induction Rectal Neoplasms Humans Cytarabine Aged Colon, Descending Leukemia, Myeloid, Acute
View on PubMed

Development of Machine Learning Models for Predicting Postoperative Delayed Remission in Patients With Cushing's Disease.

The Journal of clinical endocrinology and metabolism Jan 1, 2021
CONTEXT: Postoperative hypercortisolemia mandates further therapy in patients with Cushing's disease (CD). Delayed remission (DR) is defined as not achieving postoperative immediate remission (IR), but having spontaneous remission during long-term fo...
Computer Simulation Prognosis Retrospective Studies Female Reproducibility of Results Humans Machine Learning Algorithms China Time Factors Treatment Outcome Follow-Up Studies Models, Statistical Young Adult Adult Male Middle Aged Pituitary ACTH Hypersecretion Adenoma ACTH-Secreting Pituitary Adenoma Neurosurgical Procedures Remission Induction Postoperative Period
View on PubMed DOI

Predicting Individual Remission After Electroconvulsive Therapy Based on Structural Magnetic Resonance Imaging: A Machine Learning Approach.

The journal of ECT Sep 1, 2020
OBJECTIVE: To identify important clinical or imaging features predictive of an individual's response to electroconvulsive therapy (ECT) by utilizing a machine learning approach.
Electroconvulsive Therapy Brain Female Aged Male Middle Aged Depressive Disorder, Major Magnetic Resonance Imaging Predictive Value of Tests Remission Induction Humans Machine Learning
View on PubMed DOI

Analysis of the advantages and disadvantages in application of oxygen-driven aerosol and aerosol inhalation by air compressor for the pediatric asthma.

Pakistan journal of pharmaceutical sciences Nov 1, 2018
Present study is done to analyze the advantages and disadvantages in application of oxygen-driven aerosol and aerosol inhalation by air compressor for the pediatric asthma. A total of 180 patients with pediatric bronchial asthma were randomized into ...
Budesonide Humans Compressed Air Female Oxyhemoglobins Asthma Male Child Remission Induction Treatment Outcome Administration, Inhalation Oxygen Aerosols Albuterol
View on PubMed

Predicting Corticosteroid-Free Biologic Remission with Vedolizumab in Crohn's Disease.

Inflammatory bowel diseases May 18, 2018
BACKGROUND AND AIMS: Vedolizumab (VDZ) is effective for Crohn's disease (CD) but costly and is slow to produce remission. Early knowledge of whether vedolizumab is likely to succeed is valuable for physicians, patients, and insurers.
Gastrointestinal Agents Female Remission Induction Young Adult Adrenal Cortex Hormones Adult Biological Products Male C-Reactive Protein Middle Aged Area Under Curve Humans Cohort Studies Crohn Disease Machine Learning ROC Curve Treatment Outcome Antibodies, Monoclonal, Humanized
View on PubMed DOI

Dosing interval and diagnosis predict infliximab levels in patients with inflammatory bowel disease on maintenance treatment.

Acta gastro-enterologica Belgica Jan 1, 2018
OBJECTIVE: The aim of the study was to identify factors influencing infliximab (IFX) trough levels (TL) in patients with inflammatory bowel disease (IBD).
Gastrointestinal Agents Colitis, Ulcerative Humans Remission Induction Antibodies, Monoclonal Inflammatory Bowel Diseases Infliximab Cross-Sectional Studies Crohn Disease Treatment Outcome
View on PubMed

Machine Learning Algorithms for Objective Remission and Clinical Outcomes with Thiopurines.

Journal of Crohn's & colitis Jul 1, 2017
BACKGROUND AND AIMS: Big data analytics leverage patterns in data to harvest valuable information, but are rarely implemented in clinical care. Optimising thiopurine therapy for inflammatory bowel disease [IBD] has proved difficult. Current methods u...
Female Hospitalization Young Adult Adult Male Middle Aged Adolescent Medication Adherence ROC Curve Humans Machine Learning Algorithms Inflammatory Bowel Diseases Retrospective Studies Drug Prescriptions Azathioprine Treatment Outcome Mercaptopurine Immunosuppressive Agents Area Under Curve Remission Induction
View on PubMed DOI

A comparative phase III clinical study to evaluate efficacy and safety of TrastuRel™ (biosimilar trastuzumab) and innovator trastuzumab in patients with metastatic human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer.

Indian journal of cancer Jan 1, 2017
INTRODUCTION: The present study for biosimilar trastuzumab was a multicentric, randomized, two-arm parallel-group, comparative phase III study in patients with metastatic breast cancer.
Paclitaxel Humans Disease-Free Survival Female India Receptor, ErbB-2 Aged Antineoplastic Combined Chemotherapy Protocols Adult Trastuzumab Breast Neoplasms Remission Induction Middle Aged Biosimilar Pharmaceuticals Drug-Related Side Effects and Adverse Reactions
View on PubMed DOI
Popular Topics
Recent Journals